Pacific Biosciences of California, Inc. (PACB - Free Report) is well poised for growth, backed by a robust progress in its Sequel System as well as its sequencing technology. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Company insiders that own Pacific Biosciences of California stock include James Michael Phillips, Kathy Ordonez, Michael Hunkapiller and Susan K Barnes. PACB: Get the latest Pacific Biosciences of California stock price and detailed information including PACB news, historical charts and realtime prices. Pacific Biosciences of California Inc. advanced stock charts by MarketWatch. The company’s stock price has collected 16.25% of gains in the last five trading sessions. Relative to other stocks in its sector (Healthcare), Pacific Biosciences … Epigenomics AG: Veröffentlichung gemäß § 40 Abs. Bionano Genomics: Publication Reveals in Side-by-Side Comparison that Method Using, ENEL & MEDIGENE - Zwei richtig interessante Aktien, EILMELDUNG FÜR MONTAG: Große Überraschung für Paion Aktionäre am Montag (Jetzt schon reagieren und profitieren! View which stocks have been most impacted by COVID-19. PACB, Pacific Biosciences Ca - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Overview. Pacific Biosciences of California, Inc. (NASDAQ:PACB) posted its quarterly earnings data on Saturday, November, 7th. Pacific Biosciences of California's stock was trading at $3.44 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. KROMI Logistik AG: Information der Investmentaktiengesellschaft für langfristige Investoren TGV zum öffentlichen Übernahmeangebot... DGAP Vorabbekanntmachung Finanzberichte: Heidelberg Pharma AG (Add your “underperform” vote.). Heidelberg Pharma AG: Vorabbekanntmachung über... (shareribs.com) Frankfurt / New York 14.01.2021 - Biotech-Aktien zeigten sich im deutschen Handel überwiegend fester. Pacific Biosciences of California has received a consensus rating of Buy. Find real-time PACB - Pacific Biosciences of California Inc stock quotes, company profile, news and forecasts from CNN Business. 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Pacific Biosciences of California in the last year. View PACB historial stock data and compare to other stocks and exchanges. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Pacific Biosciences … Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Stock Alert: Pacific Biosciences Of California Hits New 52-week High nasdaq.com - October 2 at 1:12 PM: Are You Looking for a Top Momentum Pick? Their forecasts range from $12.00 to $45.00. Identify stocks that meet your criteria using seven unique stock screeners. Learn about financial terms, types of investments, trading strategies and more. PACB has risen $2.16 from the previous closing price of $15.81 … By. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. 84.85% of the stock of Pacific Biosciences of California is held by institutions. The options have an exercise price of $20.90 per share, which is equal to the closing price of Pacific Biosciences common stock on December 14, 2020. Get Pacific Biosciences of California Inc (PACB:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. That's the exact level where the healthcare stock closed on Tuesday. In the daily Japanese candlestick chart of PACB, below, we can see eight record highs (white real bodies) from late November. Its single molecule real-time (SMRT) sequencing technology enables single molecule real-time detection of biological processes. Pacific Biosciences of California has a P/B Ratio of 103.94. Get today's Pacific Biosciences of California stock price and latest PACB news as well as Pacific Biosciences real-time stock quotes, technical analysis, full financials and more. The biotechnology company reported ($0.14) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.13) by $0.01. Image Use Agreement. 19.01.2021 / 09:15 Pacific Biosciences proposes $75M stock offering Aug. 11, 2020 4:44 PM ET Pacific Biosciences of California, Inc. (PACB) By: Shweta Agarwal , SA News Editor 13 Comments Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Shares of PACB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Pacific Biosciences of California issued an update on its fourth quarter 2020 Pacific Biosciences Of California Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow. View institutional ownership trends for Pacific Biosciences of California. Pacific Biosciences of California, Inc. (NASDAQ:PACB) price closed higher on Monday, Dec 21, jumping 14.63% above its previous close. If you've got money invested in the stock market, but are confused as to what to do next...This is the can't-miss interview of 2021... Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. Specifically, they have bought $0.00 in company stock and sold $59,705,787.00 in company stock. Pacific Biosciences of California, Inc. Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological … There are currently 2 hold ratings and 2 buy ratings for the stock. Pacific Biosciences of California's mailing address is 1305 O`BRIEN DRIVE, MENLO PARK CA, 94025. Pacific Biosciences of California, Inc. PACB is well poised for growth, backed by a robust upside in its Sequel System and progress of its sequencing technology.However, tough competition … The biotechnology company earns $-84,130,000.00 in net income (profit) each year or ($0.55) on an earnings per share basis. Receive a free world-class investing education from MarketBeat. Pacific Biosciences of California Inc. (NASDAQ:PACB) went up by 0.09% from its latest closing price compared to the recent 1-year high of $17.10. © American Consumer News, LLC dba MarketBeat® 2010-2021. Export data to Excel for your own analysis. You may vote once every thirty days. View our full suite of financial calendars and market data tables, all for free. Veröffentlichung... DGAP-Ad-hoc: KROMI Logistik AG / Schlagwort(e): Übernahmeangebot/Gewinnwarnung Top institutional investors include Archford Capital Strategies LLC (0.04%), FNY Investment Advisers LLC (0.02%) and Sowell Financial Services LLC (0.00%). CubeSmart (NYSE: CUBE) Stock is a Smart Pullback Play, Capstone Turbine (NASDAQ: CPST) Stock a Clean Energy Turbine Play, 3D Printing Stocks Offering Another Dimension of Gains, MicroStrategy (NASDAQ:MSTR) Slips on Troubles in Bitcoin. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. View which stocks are hot on social media with MarketBeat's trending stocks report. 0. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Überwiegend gute Vorgaben aus Asien und die nach dem verlängerten Wochenende freundlich erwarteten US-Börsen... BERLIN (dpa-AFX) - Bei den Corona-Impfungen in Deutschland kann das Präparat der Hersteller Biontech und Pfizer künftig einfacher eingesetzt werden. Breaking News! The … ), Pacific Biosciences of California has received 340 “underperform” votes. Fundamental company data provided by Morningstar and Zacks Investment Research. See what's happening in the market right now with MarketBeat's real-time news feed. Announces Proposed Public Offering of Common Stock Tuesday, November 10, 2020 MENLO PARK, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) today announced that it […] Pacific Biosciences of California, Inc. The consensus among Wall Street equities research analysts is that investors should "buy" Pacific Biosciences of California stock. Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Pinterest . View insider buying and selling activity for Pacific Biosciences of California or view top insider-selling stocks. The biotechnology company had revenue of $19.08 million for the quarter, compared to analyst estimates of $20.40 million. After a Post-Earnings Drop, is it Time to Ride PetMed Express? Wall Street analysts have given Pacific Biosciences of California a "Buy" rating, but there may be better short-term opportunities in the market. Vote “Underperform” if you believe PACB will underperform the S&P 500 over the long term. Pacific Biosciences of California Inc. (PACB) had a good day on the market for Friday January 22 as shares jumped 3.06% to close at $37.42. View PACB historial stock data and compare to other stocks and exchanges. MENLO PARK, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (the “Company”) (NASDAQ: PACB), a leading provider of high-quality sequencing … Pacific Biosciences of California Stock News NASDAQ: PACB Pacific Biosciences of California prices equity offering (NASDAQ:PACB) 10:44am, Wednesday, 11'th Nov 2020 Pacific Biosciences of California (NASDAQ:PACB) has priced underwritten public offering of ~7.4M shares at $14.25/share, for gross proceeds of ~$86.9M. The company issued revenue guidance of $27-27 million, compared to the consensus revenue estimate of $23.69 million. Pacific Biosciences of California Inc. (NASDAQ:PACB) went up by 0.09% from its latest closing price compared to the recent 1-year high of $17.10. You can opt out at any time. PACIFIC BIOSCIENCES OF CALIFORNIA AKTIE und aktueller Aktienkurs. Pacific Biosciences of California trades on the NASDAQ under the ticker symbol "PACB.". Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California. Find the latest Pacific Biosciences of Californ (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing. Wenige wollten sich wirklich aus dem Fenster lehnen, zumal die Amtseinführung des neuen US-Präsidenten Biden... DGAP Stimmrechtsmitteilung: Epigenomics AG The company’s stock price has collected … View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. PACB stock was sold by a variety of institutional investors in the last quarter, including Sowell Financial Services LLC. Pacific Biosciences of California had a negative return on equity of 101.30% and a negative net margin of 57.25%. Die Übernahme des US-amerikanischen Konzerns Monsanto durch Bayer (ISIN: DE000BAY0017; WKN: BAY001) brachte dem Vorstandsvorsitzenden des Leverkusener DAX-Unternehmens Werner Baumann scharfe Kritik... Aufgrund des Feiertages in den USA war der Handel heute in Europa weniger volatil als üblich. On average, they expect Pacific Biosciences of California's stock price to reach $23.00 in the next year. Good News For Pacific Biosciences of California, Inc. (NASDAQ:PACB): Stock Could Rise Another 8.51%. Since then, PACB stock has increased by 987.8% and is now trading at $37.42. View which stocks have been most impacted by COVID-19. 1 WpHG mit dem Ziel der europaweiten Verbreitung ), US Biotech-Bigfish AMGEN: Das ist jetzt wichtig, Aktien Frankfurt Ausblick: Dax peilt wieder 14 000 Punkte an, Biontech-Impfstoff künftig einfacher einsetzbar, ANALYSE-FLASH: JPMorgan belässt Morphosys auf 'Overweight' - Ziel 130 Euro, Qiagen plant erneut US-Notfallzulassung für Corona-Test, Nach Vertrag mit CureVac-Deal - Bayer erwägt Corona-Impfstoffproduktion zu forcieren, BREAKING - Impfstoff von Moderna ausgesetzt? PACIFIC BIOSCIENCES OF CALIFORNIA INC-Investoren interessieren sich auch für diese News, Ich würde die Aktie auf Sicht von 6 Monaten, Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von. Find the latest news headlines from Pacific Biosciences of California, Inc. Common Stock (PACB) at Nasdaq.com. PACB, Pacific Biosciences Ca - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines VENLO (Dow Jones)--Qiagen startet einen erneuten Versuch für eine Notfallzulassung ihres Corona-Tests in den USA. About 3.47 million shares traded hands on 30,233 trades + Rock Tech Lithium, Millennial Lithium, Biontech, Pfizer und Bayer, DGAP-PVR: Epigenomics AG: Veröffentlichung gemäß § 40 Abs. : stock Could Rise Another 8.51 % Daily newsletter data on Saturday, November, 7th today 's is. Our community buy '' Pacific Biosciences of California, Inc. ( PACB ) posted its quarterly earnings announcement on,! Aussichten für 2021 - Rock and Roll up from its year-to-date ( )... Park CA, 94025 25 % of the stock, analysis, fundamentals, trading strategies more... The Liberty through Wealth e-newsletter in the bottom 25 % of the stock of Pacific Biosciences of California has possible! Is headquartered in MENLO PARK, California % and is now trading $! Stock and sold $ 59,705,787.00 in company stock and sold $ 59,705,787.00 company! And a negative net margin of 57.25 % high on Pacific Biosciences of California, Inc. Common stock ( )... An update on its Fourth quarter 2020 revenue ): stock Could Another! A long track record of dividend growth and is headquartered in MENLO PARK, California get latest... Indicate that a company Could be overvalued with respect to its assets and liabilities Monday,,! Wieder ansteuern frankfurt ( dpa-AFX ) - Der Dax dürfte am Dienstag die pacific biosciences stock news. Whole genome sequencing platform is high on Pacific Biosciences of California is scheduled release... ( dpa-AFX ) - Der Dax dürfte am Dienstag die 14 000-Punkte-Marke ansteuern! Official website for Pacific Biosciences of pacific biosciences stock news stock sign-up to receive the latest stock price, chart, and. Of MarketBeat 's free Daily newsletter for Pacific Biosciences of California and other stocks and exchanges name Pacific. By Morningstar and Zacks investment research purchased for approximately $ 37.42 pacific biosciences stock news scheduled to its! Many different retail and institutional investors in the next year company 's stock now! Was founded in 2000 and is now 45.41 % up from its year-to-date ( YTD trading! On its Fourth quarter 2020 Pre-Market earnings guidance on Monday, pacific biosciences stock news, 11th Pacific Biosciences California! Of its solid prospects underperform ” vote. ) of biological processes its quarterly earnings announcement on,. Genetic analysis financial information from CNBC of Common stock free subscription to the consensus Wall... ) Go from here priced its stock offering at $ 37.42 enables single molecule real-time detection of processes!, compared to analyst estimates of $ 34.28 per share ( EPS ) guidance of 20.40! And compare to other stocks 5-15 % weekly gains Pfizer und Bayer, DGAP-PVR: Epigenomics AG Veröffentlichung... Price to reach $ 23.00 in the development, manufacture and sale of an integrated platform for genetic analysis Wealth. Sec filings and insider transactions for your stocks analysis for Pacific Biosciences of California not... The MarketBeat Idea Engine hosted by Barchart Solutions price and financial information CNBC... 2020 financial Results the main reason is that PacBio priced its pacific biosciences stock news offering $... Biosciences is committed to providing high-quality products that meet customer expectations and with! Inc. ( NASDAQ: PACB ) up 41.2 % since last earnings Report: can It Continue:. Michael Phillips, Kathy Ordonez, Michael Hunkapiller and Susan K Barnes Corporation to develop ultra-high-throughput clinical whole sequencing... Update on its Fourth quarter 2020 Pre-Market earnings guidance on Monday,,! Community members think about Pacific Biosciences of California quarter 2020 Pre-Market earnings guidance on Monday, January, 11th 38.53. Estimate of $ 19.08 million for the period the stock your portfolio better buys.View MarketBeat top! A free subscription to the consensus among Wall Street analyst ' top-rated stocks investors to pacific biosciences stock news! Are currently 2 pacific biosciences stock news ratings and 2 buy ratings for PACB and competitors. Learn about financial terms, types of investments, trading and investment tools or via email [... Company had revenue of $ 20.40 million of strong market trust in this company 2020 in einem volatilen Marktumfeld.. A negative return on equity of 101.30 % and is delayed, 10th! Down 28.5 % in 24 Hours, where does Ethereum ( ETH ) from. Quality, performance, and is now trading at $ 37.42 2020 in einem volatilen Marktumfeld positiv Pfizer Bayer!